Genedx Holdings Corp Stock Performance
| WGSWW Stock | 0.15 0.02 11.76% |
GeneDx Holdings holds a performance score of 22 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.42, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GeneDx Holdings will likely underperform. Use GeneDx Holdings Corp expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to analyze future returns on GeneDx Holdings Corp.
Risk-Adjusted Performance
22 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in GeneDx Holdings Corp are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, GeneDx Holdings showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | GeneDx Holdings Corp Shares Up 3.59 percent on Sep 19 - GuruFocus.com | 09/19/2024 |
2 | Rhumbline Advisers Purchases 18,136 Shares of GeneDx Holdings Corp. - MarketBeat | 09/27/2024 |
3 | After Leaping 53 percent GeneDx Holdings Corp. Shares Are Not Flying Under The Radar - Simply Wall St | 10/04/2024 |
4 | WGS - GeneDx Holdings Corp. Latest Stock News Market Updates - StockTitan | 11/07/2024 |
5 | Genedx director Ryan sells shares worth 3.3 million - Investing.com | 11/21/2024 |
| Begin Period Cash Flow | 137.4 M | |
| Free Cash Flow | -185.9 M |
GeneDx |
GeneDx Holdings Relative Risk vs. Return Landscape
If you would invest 2.68 in GeneDx Holdings Corp on August 30, 2024 and sell it today you would earn a total of 12.32 from holding GeneDx Holdings Corp or generate 459.7% return on investment over 90 days. GeneDx Holdings Corp is currently producing 3.3505% returns and takes up 11.9719% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than GeneDx, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GeneDx Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneDx Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GeneDx Holdings Corp, and traders can use it to determine the average amount a GeneDx Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2799
| Best Portfolio | Best Equity | |||
| Good Returns | WGSWW | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.97 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.35 actual daily | 66 66% of assets have lower returns |
Risk-Adjusted Return
| 0.28 actual daily | 22 78% of assets perform better |
Based on monthly moving average GeneDx Holdings is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeneDx Holdings by adding it to a well-diversified portfolio.
GeneDx Holdings Fundamentals Growth
GeneDx Stock prices reflect investors' perceptions of the future prospects and financial health of GeneDx Holdings, and GeneDx Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GeneDx Stock performance.
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.10) % | ||||
| Revenue | 202.57 M | ||||
| EBITDA | (136.46 M) | ||||
| Net Income | (175.77 M) | ||||
| Total Debt | 119.77 M | ||||
| Book Value Per Share | 7.45 X | ||||
| Cash Flow From Operations | (180.15 M) | ||||
| Total Asset | 473.67 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 123.52 M | ||||
About GeneDx Holdings Performance
Evaluating GeneDx Holdings' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if GeneDx Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GeneDx Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 22.57 | 40.43 | |
| Return On Tangible Assets | (0.58) | (0.61) | |
| Return On Capital Employed | (0.39) | (0.41) | |
| Return On Assets | (0.37) | (0.39) | |
| Return On Equity | (0.77) | (0.81) |
Things to note about GeneDx Holdings Corp performance evaluation
Checking the ongoing alerts about GeneDx Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GeneDx Holdings Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GeneDx Holdings Corp is way too risky over 90 days horizon | |
| GeneDx Holdings Corp has some characteristics of a very speculative penny stock | |
| GeneDx Holdings Corp appears to be risky and price may revert if volatility continues | |
| GeneDx Holdings Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 202.57 M. Net Loss for the year was (175.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| GeneDx Holdings generates negative cash flow from operations | |
| GeneDx Holdings Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Genedx director Ryan sells shares worth 3.3 million - Investing.com |
- Analyzing GeneDx Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GeneDx Holdings' stock is overvalued or undervalued compared to its peers.
- Examining GeneDx Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GeneDx Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GeneDx Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GeneDx Holdings' stock. These opinions can provide insight into GeneDx Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.